Hi, welcome to the first session in 2023; we are digging more into the data to get more helpful information.

So here is Q1-2023 but:-
We haven't heard any news about SODIC, and Orascom Development deal regarding O-West acquisition, so remember and keep it on your notes.
The pharmaceuticals sector didn't join the market rally at the same pace during November and December.
Higher interest rates benefit corporations' treasury by creating additional profits from the overnight rate.
Finally, Ezz Steel starting his first session in 2023 by a +7% increase
Comments